Windlas Biotech Ltd Quarterly Results

Gross Sales

210.09

202.71

195.02

187

175.15

Excise Duty

0

0

0

0

0

Net Sales

210.09

202.71

195.02

187

175.15

Other Operating Income

0

0

0

0

0

Other Income

5.24

4.94

4.11

4.84

4.13

Total Income

215.33

207.64

199.13

191.84

179.29

Total Expenditure

183.57

177.16

170.39

163.95

154.27

PBIDT

31.76

30.49

28.74

27.89

25.01

Interest

1.06

1.33

1.46

1.1

0.49

PBDT

30.71

29.16

27.28

26.79

24.52

Depreciation

7.45

8.34

6.94

6.5

6.21

Minority Interest Before NP

0

0

0

0

0

Tax

5.55

4.61

3.94

5.13

4.61

Deferred Tax

0.04

-0.06

0.82

-0.5

0.22

Reported Profit After Tax

17.66

16.28

15.58

15.66

13.48

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

17.66

16.28

15.58

15.66

13.48

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

17.66

16.28

15.58

15.66

13.48

EPS (Unit Curr.)

8.43

7.77

7.45

7.49

6.47

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.48

10.48

10.45

10.45

10.45

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.11

15.04

14.73

14.91

14.27

PBDTM(%)

14.61

14.38

13.98

14.32

13.99

PATM(%)

8.4

8.03

7.98

8.37

7.69